{
    "2021-09-21": [
        [
            {
                "time": "2021-11-15",
                "original_text": "Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Cash Tender Offer",
                        "Debt Securities"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "EU signs joint procurement deal for Eli Lilly COVID-19 treatment",
                "features": {
                    "keywords": [
                        "EU",
                        "procurement deal",
                        "Eli Lilly",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "UPDATE 1-Lilly to supply up to 220,000 COVID-19 antibody combo doses to European countries",
                "features": {
                    "keywords": [
                        "Lilly",
                        "antibody combo",
                        "European countries"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "international"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19",
                "features": {
                    "keywords": [
                        "Lilly",
                        "procurement agreement",
                        "European Commission",
                        "bamlanivimab",
                        "etesevimab"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Do Eli Lilly's (NYSE:LLY) Earnings Warrant Your Attention?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "earnings",
                        "attention"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps for Its 3.950% Notes due 2049 and Its 4.150% Notes due 2059",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Early Tender Results",
                        "Cash Tender Offer",
                        "Debt Securities"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}